grinboss

CVS Health

CVS

What is it worth to you? Move six assumptions and see what value per share you get, and where you stand against the price and other users.

At $81.35 (close on November 18) and with the other assumptions at their starting point, CVS Health's sales would need to grow 5.5% a year for ten years; over its last decade, the median was 8.3%. Value it with your own assumptions.

Its accounts, year by year

Year endSalesGrowthMargin
12/2015153,290—6.3%
12/2016177,54615.8%6.0%
12/2017184,7864.1%5.3%
12/2018194,5795.3%2.2%
12/2019256,77632.0%4.8%
12/2020268,7064.6%5.3%
12/2021292,1118.7%4.7%
12/2022322,46710.4%2.6%
12/2023357,77610.9%4.0%
12/2024372,8094.2%2.4%
12/2025402,0677.8%1.3%

Sales in millions of dollars. The margin is the operating margin before stock pay, as a percentage of sales. Each row is a fiscal year, by the month it ends. Source: the reports CVS Health files with the SEC, the US securities regulator; the latest is for the fiscal year ended December 31, 2025. See the report.

The model's starting point

  • Sales growth, years 1 to 10: 8.7% a year.
  • Sales growth after year 10: 2.5% a year.
  • Operating margin, before stock pay: 2.4% of sales.
  • Working capital needed to grow: −$4.1 per $100 of new sales.
  • Capital spending: 0.8% of sales.
  • Stock pay to employees: 0.2% of sales.
  • Discount rate, the same for every company: 10%.

These are the six assumptions the page starts with; each user moves them as they see fit.

Reference points

They come from its accounts and its share price, compared with the median of the companies on grinboss. They are not a recommendation.

For

  • It is one of the big ones: it sells $402.1 billion a year; the median of grinboss companies is $15.1 billion.
  • Its stock pay to employees is low: 0.2% of sales; the median is 1.5%.
  • It needs little investment: its capital spending takes 0.8% of its sales; the median is 3.3%.
  • It sold more than the year before in 10 of the last 10 years.

Against

  • It makes only $2 of operating profit for every $100 it sells, before stock pay; the median is $18.
  • It owes a lot: its net debt equals 4.9 years of operating profit plus depreciation and amortization (EBITDA), more than the median (1.5).
  • Its margin has fallen over these years, from 6% to 2%.
  • Over ten years it fell as much as 60% from its high; the median is 56%.

Next results: February 9, 2027.

Other companies in its sector (Health Care)

Quest Diagnostics (DGX) · Danaher Corporation (DHR) · DaVita (DVA) · Dexcom (DXCM) · Edwards Lifesciences (EW) · GE HealthCare (GEHC) · Gilead Sciences (GILD) · HCA Healthcare (HCA) · All companies

Loading the model…